Propel Bio Partners Launches With Backing of Richard Kayne
The firm, co-led by the Kayne Anderson co-founder, seeks $150 million for its first fund Kayne Anderson Capital Advisors co-founder...
As a notable CEO at the intersection of technology and biotech, Dr. Kawas is often featured in various industry media.